Table 1.
C32 patients | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | All |
No of patients | 2965 | 2682 | 2653 | 2571 | 2520 | 2539 | 2360 | 2350 | 2317 | 22 957 |
Population (in thousands) | 38 517 | 38 526 | 38 534 | 38 502 | 38 484 | 38 455 | 38 427 | 38 422 | 38 413 | — |
Incidence rate* | 7.70 | 6.96 | 6.88 | 6.68 | 6.55 | 6.60 | 6.14 | 6.12 | 6.03 | — |
Age mean±SE | 62.33±9.43 | 62.72±9.27 | 62.72±9.19 | 63.42±9.13 | 63.56±8.87 | 64.1±8.72 | 64.05±8.99 | 64.49±8.99 | 64.82±8.97 | 63.58±9.06 |
Women (%) |
388 (13.09) | 336 (12.53) | 351 (13.23) | 364 (14.16) | 351 (13.93) | 353 (13.9) | 330 (13.98) | 308 (13.11) | 330 (14.24) | 3111 (13.57) |
Men (%) |
2577 (86.91) | 2346 (87.47) | 2302 (86.77) | 2207 (85.84) | 2169 (86.07) | 2186 (86.10) | 2030 (86.02) | 2042 (86.89) | 1987 (85.76) | 19 846 (86.43) |
Urban residence (%) | 2184 (73.66) | 1940 (72.33) | 1913 (72.11) | 1868 (72.66) | 1802 (71.51) | 1822 (71.76) | 1672 (70.85) | 1666 (70.89) | 1617 (69.79) | 16 484 (71.73) |
Rural resistance (%) |
781 (26.34) | 742 (27.67) | 740 (27.89) | 703 (27.34) | 718 (28.49) | 717 (28.24) | 688 (29.15) | 684 (29.11) | 700 (30.21) | 6473 (28.27) |
*Incidence rate=no of all C32 new diagnoses/100 000 citizens